Chiara Recchi
London, ENG W120NN, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.
Journal: Molecular therapy. Advances
Published: February 06, 2026
Restoration of progranulin by engineered hematopoietic stem cell-derived microglia corrects phenotypes of granulin knockout mice.
Journal: Science translational medicine
Published: January 07, 2026
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.
Journal: Cancer gene therapy
Published: March 07, 2020
Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer.
Journal: Frontiers in pharmacology
Published: May 31, 2018
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
Journal: EMBO reports
Published: December 19, 2017
The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer.
Journal: Molecular cancer therapeutics
Published: January 30, 2017
Correction: A Role for Na+,K+-ATPase α1 in Regulating Rab27a Localisation on Melanosomes.
Journal: PloS one
Published: February 04, 2016
Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design.
Journal: Current topics in medicinal chemistry
Published: January 03, 2016
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.
Journal: Cell death and differentiation
Published: December 22, 2015
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.
Journal: Breast cancer research and treatment
Published: August 26, 2014
Last Updated: 09/26/2026